Long-term complete remission in IgD-myeloma

Long-term complete remission in IgD multiple myeloma (MM) is rare. This case report describes a patient with a stage IIIB IgD-MM, who was treated with conventional melphalan and prednisone chemotherapy. The monoclonal protein disappeared after four cycles and therapy was discontinued after 14 cycles. Re-evaluation after a follow up of more than 8 years demonstrates a continuing complete remission suggesting a cure. This is remarkable, considering that several adverse prognostic factors were present. In addition a concise review on IgD-MM is given.

Eur J Haematol. 2006 Apr;76(4):339-41

Bemelmans RH, van Toorn DW, van Leeuwen L, Schaar CG.

Department of Internal Medicine, Gelre Hospitals, Apeldoorn, The Netherlands.

PMID: 16519706 [PubMed - in process]